MARCH 2006
		EDITOR'S PAGE Your New Comprehensive Retina Resource By Conni Koury, Editor-in-Chief VITREOUS Vitrase was Effective for Vitreous Hemorrhage Management By Baruch D. Kuppermann, MD, PhD Changing Surgical Approaches for Retinal Detatchment By Donald J. D’Amico, MD DIABETES Is Glycemic Control Necessary During Cataract Surgery in Diabetic Patients? By Chikako Suto, MD; and Sadao Hori, MD Move Over Digital Imaging, Make Room for an Administration System By Laura Suarez, Managing Editor RETINAL IMAGING Advances in OCT Technology Improve Understanding of Disease States By Jay S. Duker, MD COVER FOCUS The Future of CRVO, BRVO and DME Therapies By Michael S. Ip, MD Targeting VEGF in AMD By Rishi P. Singh, MD; and Peter K. Kaiser, MD Bevacizumab in the Treatment of Ocular Disease By Dante J. Pieramici, MD; and Robert L. Avery, MD Considerations for Intravitreal Triamcinolone Use By Laura Suarez, Managing Editor Adding IVTA to PRP for Diabetic Retinopathy Patients With CSME Appears Promising By Conni Bergmann Koury, Editor-in-Chief Pegaptanib Safety Profile Maintained Through 2 Years By Conni Bergmann Koury, Editor-in-Chief Prevalence of AMD in Whites, Blacks, Hispanics and Chinese By Conni Bergmann Koury, Editor-in-Chief Clinical Trials Continuing Medical Education Innovations 5 Questions with Lois E.H. Smith, MD, PhD